Class-action lawsuits make news for their big sums – last year, pharmaceutical giant Merck settled a suit over its heart drug Vioxx for $37-million – but a more prosaic challenge gets less attention.
After 13 years at the helm of Canada's national pharmacists' advocacy group, Jeff Poston has announced his retirement as executive director of the Canadian Pharmacists' Association.
